Biosimilars’ Adaptation in Europe – Considerations Beyond Price
By EsqSocial Corporation 08/09/16
Precision for Value evaluated various considerations that factor into the level of biosimilars uptake, focusing primarily on Europe’s recent introduction of biosimilar anti-tumor necrosis factor drugs (anti-TNF drugs). Amongst its findings, the...
By: Goodwin